[Relationship between inflammation marker and all-cause and cardiovascular mortality in a prospective cohort study].
| Autor: | Carbayo Herencia JA; Unidad de Lípidos, Capio Clínica Albacete, Albacete, España. jacarbayoh@telefonica.net, Simarro Rueda M, Artigao Ródenas LM, Divisón Garrote JA, Caldevilla Bernardo D, Ponce García I, Sanchis Domènech C |
|---|---|
| Jazyk: | Spanish; Castilian |
| Zdroj: | Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis [Clin Investig Arterioscler] 2013 Apr-Jun; Vol. 25 (2), pp. 56-62. Date of Electronic Publication: 2013 Feb 19. |
| DOI: | 10.1016/j.arteri.2013.01.002 |
| Abstrakt: | Introduction: Inflammation is present in every stage of the atherosclerosis process, therefore, inflammation hallmarks such as the fibrinogen can be related to the complications in which it intervenes, mortality is one of them. The objective of this study is to assess the association of the fibrinogen with all-cause mortality in men from general population sample obtained by random sampling in the Spanish region of Albacete. Methods: A total of 506men without cardiovascular events with 10.6years (SD=2.3) of follow-up, volunteered to participate in a prospective cohort study. The assessment of the fibrinogen as a predictor variable has been calculated after adjusting it by age, hypertension, diabetes mellitus, obesity, total cholesterol, HDL-cholesterol/triglycerides ratio, and smoking habit applying a Cox regression model. The adjustment has been made by adding the fibrinogen to the model, as a qualitative variable (<400 and ≥400mg/dl). Results: The average age of the participants was 46.6years old (DE=16.8). After the adjustment, the hyperfibrinogenemia (≥400mg/dl) showed a hazard ratio (HR) for all-cause mortality of 1.85 (95%CI: 1.05-3.26) and for cardiovascular mortality HR=2.69 (95%CI: 1.09-6.63). Conclusions: In men without cardiovascular events of our study, fibrinogen was showed as an independent predictor of all-cause mortality and cardiovascular mortality. (Copyright © 2012 Elsevier España, S.L. and SEA. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|